Belgía - enska - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

zoetis belgium sa-nv - clostridium haemolyticum toxoid >= 16,5 u/ml; tetanus toxoid >= 2,5 u/ml; clostridium septicum toxoid >= 3,6 u/ml; clostridium novyi toxoid >= 1,2 u/ml; clostridium perfringens type c (beta) toxoid >= 12,4 u/ml; clostridium perfringens type d (epsilon) toxoid >= 5,1 u/ml; clostridium perfringens type a toxoid >= 0,9 u/ml; clostridium perfringens type b toxoid >= 12,4 u/ml; clostridium chauvoei (inactivated) ; clostridium sordellii toxoïd >= 0,8 u/ml - suspension for injection - clostridium chauvoei-septicum; clostridium haemolyticum toxoid; clostridium novyi toxoid; clostridium perfringens; clostridium tetani toxoid; clostridium sordellii toxoid - clostridium - cattle; sheep

Nýja-Sjáland - enska - Ministry for Primary Industries

zoetis new zealand limited - clostridium tetani toxoid; streptococcus equi - clostridium tetani toxoid 0 vaccine; streptococcus equi 0 vaccine - vaccine

Nýja-Sjáland - enska - Ministry for Primary Industries

zoetis new zealand limited - clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells; clostridium septicum toxoid; clostridium sordellii toxoid/cells; clostridium novyi type b toxoid/cells; clostridium tetani toxoid - clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium septicum toxoid 0 vaccine; clostridium sordellii toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine - vaccine

Nýja-Sjáland - enska - Ministry for Primary Industries

zoetis new zealand limited - clostridium septicum toxoid; clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells; clostridium tetani toxoid - clostridium septicum toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium tetani toxoid 0 vaccine - vaccine

Nýja-Sjáland - enska - Ministry for Primary Industries

schering-plough animal health limited - clostridium tetani toxoid; sodium selenate; clostridium septicum toxoid; clostridium chauvoei toxoid/cells; clostridium novyi type b toxoid/cells; clostridium perfringens type d toxoid; levamisole phosphate - clostridium tetani toxoid 0 vaccine; sodium selenate 1.25 g/litre; clostridium septicum toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine; clostridium novyi type b toxoid/cells 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; levamisole phosphate 100 g/litre - endoparasiticide

Nýja-Sjáland - enska - Ministry for Primary Industries

schering-plough animal health limited - clostridium novyi type b toxoid/cells; hydroxocobalamin acetate; clostridium septicum toxoid; clostridium tetani toxoid; clostridium perfringens type d toxoid; clostridium chauvoei toxoid/cells - clostridium novyi type b toxoid/cells 0 vaccine; hydroxocobalamin acetate 1 g/litre; clostridium septicum toxoid 0 vaccine; clostridium tetani toxoid 0 vaccine; clostridium perfringens type d toxoid 0 vaccine; clostridium chauvoei toxoid/cells 0 vaccine - parenteral nutrient/electrolyte

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - levamisole; clostridium chauvoei - killed; clostridium novyi type b - killed; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - levamisole anthelmintic active 68.0 g/l; clostridium chauvoei - killed vaccine-microbial active 0.0 p; clostridium novyi type b - killed vaccine-microbial active 0.0 p; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; thiomersal mercury other 0.15 mg/ml - immunotherapy - sheep - not lambs | ewe | ovine | ram - barber's pole worm - haemonchus spp. | black disease | black scour worm - trichostrongylus spp. | blackleg | enterotoxaemia (pulpy kidney) | intestinal threadworm-strongyloides spp. | large bowel worm - oesophagostomum spp. | lungworm - dictyocaulus spp. | malignant oedema | small brown stomach worm-ostertagia spp. | small intestinal worm - cooperia spp. | stomach hair worm | tetanus | thin necked intestinal worm | vaccine | clostridium perfringens type d | equine rotavirus | hair worm | intestinal hair worm | pole worm | small hair worm | teladorsagia | tetanus vaccination

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; corynebacterium pseudotuberculosis - toxoid - misc. vaccines or anti sera - selenium as sodium selenate mineral-selenium active 0.5 g/l; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 p; clostridium novyi type b - toxoid vaccine-toxoid active 0.0 p; clostridium perfringens type d toxoid vaccine-toxoid active 0.0 p; clostridium septicum - toxoid vaccine-toxoid active 0.0 p; clostridium tetani - toxoid vaccine-toxoid active 0.0 p; corynebacterium pseudotuberculosis - toxoid vaccine-toxoid active 0.0 p - immunotherapy - lamb | sheep | ewe | hogget | lamb | ovine | ram | weaner | wether - black disease | blackleg | cheesy gland | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | clostridium perfringens type d | lymphadenitis | lymphangitis | tetanus vaccination | white muscle disease

Ástralía - enska - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - selenium as sodium selenate; clostridium chauvoei - toxoid; clostridium novyi type b - toxoid; clostridium perfringens type d toxoid; clostridium septicum - toxoid; clostridium tetani - toxoid; thiomersal - misc. vaccines or anti sera - selenium as sodium selenate mineral-selenium active 0.5 g/l; clostridium chauvoei - toxoid vaccine-toxoid active 0.0 ph.eur.; clostridium novyi type b - toxoid vaccine-toxoid active 3.5 units/ml; clostridium perfringens type d toxoid vaccine-toxoid active 5.0 units/ml; clostridium septicum - toxoid vaccine-toxoid active 2.5 units/ml; clostridium tetani - toxoid vaccine-toxoid active 2.5 units/ml; thiomersal mercury other 0.15 mg/ml - immunotherapy - cattle | goat | lamb | sheep | beef | billy | bos indicus | bos taurus | bovine | buck | buffalo | bull | bullock | calf | capra - black disease | blackleg | enterotoxaemia (pulpy kidney) | malignant oedema | selenium deficiency | tetanus | clostridium perfringens type d | tetanus vaccination | white muscle disease

Bandaríkin - enska - NLM (National Library of Medicine)

grifols usa, llc - human clostridium tetani toxoid immune globulin (unii: v4swi4rf4j) (human clostridium tetani toxoid immune globulin - unii:v4swi4rf4j) - human clostridium tetani toxoid immune globulin 250 [iu] in 1 ml - hypertet is indicated for prophylaxis against tetanus following injury in patients whose immunization is incomplete or uncertain (see below). it is also indicated, although evidence of effectiveness is limited, in the regimen of treatment of active cases of tetanus.(8,9,16) a thorough attempt must be made to determine whether a patient has completed primary vaccination. patients with unknown or uncertain previous vaccination histories should be considered to have had no previous tetanus toxoid doses. persons who had military service since 1941 can be considered to have received at least one dose, and although most of them may have completed a primary series of tetanus toxoid, this cannot be assumed for each individual. patients who have not completed a primary series may require tetanus toxoid and passive immunization at the time of wound cleaning and debridement.(3) the following table is a summary guide to tetanus prophylaxis in wound management: none known.